Infantile Neutropenia Treatments
Find Infantile Neutropenia Treatments
Medications for Infantile Neutropenia
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Infantile Neutropenia.
Found 1 Approved Drug for Infantile Neutropenia
PegFilgrastim
Brand Names
Armlupeg, Fulphila, Fylnetra, Neulasta, Nyvepria, Stimufend, Udenyca, Ziextenzo
PegFilgrastim
Brand Names
Armlupeg, Fulphila, Fylnetra, Neulasta, Nyvepria, Stimufend, Udenyca, Ziextenzo
Form: Injection, Kit, Solution
Method of administration: Subcutaneous
FDA approval date: April 01, 2002
Classification: Leukocyte Growth Factor
Armlupeg is a leukocyte growth factor indicated to Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances